AMD to invest in PsiQuantum to advance quantum computing infrastructure
The logo of AMD at the company’s booth at the 9th China International Import Expo (CIIE) in Shanghai, China, November 5, 2026. REUTERS/Go Nakamura
Read a summary of this article on FAST.
Get bite-sized news via a new
cards interface. Give it a try.
Click here to return to FAST
Tap here to return to FAST
FAST
Nov 12 : AMD plans to make an equity investment in quantum computing company PsiQuantum as part of an expanded partnership to develop the infrastructure required for utility-scale quantum computers, the companies said on Thursday.
The deal comes when quantum computing is attracting growing investor interest as companies and governments seek systems capable of solving scientific and commercial problems too complex for conventional computers.
Breakthroughs in the technology have fueled optimism around its application in areas spanning drug discovery to financial modeling and cryptography.
The Commerce Department had in May announced plans to take minority equity stakes in nine quantum computing companies as part of a $2 billion investment under the CHIPS Act, including a $100 million deal with PsiQuantum.
Guess Word
Crack the word, one row at a time
Buzzword
Create words using the given letters
Mini Sudoku
Tiny puzzle, mighty brain teaser
Mini Crossword
Small grid, big challenge
Word Search
Spot as many words as you can
AMD, which makes chips used in data centers and AI systems, and PsiQuantum will co-design computing infrastructure for quantum systems and develop applications that combine quantum computing with high-performance computing and AI. The companies did not disclose the size of AMD’s planned equity investment.
Under the partnership, AMD will provide CPUs, GPUs, adaptive computing technology and software, while PsiQuantum will contribute its silicon photonics platform, which integrates traditional computing chip technologies with optical networking technologies that use pulses of light to transmit data.
PsiQuantum’s drug research technology is already running on AMD hardware and can produce more accurate results than existing methods, the companies said.
“The combination of PsiQuantum’s workflow with AMD’s GPU expertise running large-scale simulation has delivered initial breakthrough results in simulation of covalent inhibitors, a class of molecules relevant in drug discovery for oncology.”
Source: Reuters
Sign up for our newsletters
Get the CNA app
Stay updated with notifications for breaking news and our best stories
Get WhatsApp alerts
Join our channel for the top reads for the day on your preferred chat app
Get bite-sized news via a new
cards interface. Give it a try.
Click here to return to FAST
Tap here to return to FAST
FAST
